Correction to "Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3 H-1,2,4-triazol-3-one, by Fragment-Based Drug Design"

J Med Chem. 2021 Nov 11;64(21):16318. doi: 10.1021/acs.jmedchem.1c01685. Epub 2021 Oct 28.
No abstract available

Publication types

  • Published Erratum